Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.370
+0.070 (3.04%)
Apr 14, 2026, 4:00 PM EDT - Market closed
Codexis Employees
Codexis had 146 employees as of December 31, 2025. The number of employees decreased by 42 or -22.34% compared to the previous year.
Employees
146
Change (1Y)
-42
Growth (1Y)
-22.34%
Revenue / Employee
$482,103
Profits / Employee
-$301,192
Market Cap
215.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 146 | -42 | -22.34% | 146 | 0 |
| Dec 31, 2024 | 188 | 14 | 8.05% | 188 | 0 |
| Dec 31, 2023 | 174 | -74 | -29.84% | 174 | 0 |
| Dec 31, 2022 | 248 | -13 | -4.98% | 248 | 0 |
| Dec 31, 2021 | 261 | 80 | 44.20% | 261 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Voyager Therapeutics | 141 |
| Caribou Biosciences | 97 |
| OmniAb | 89 |
| Keros Therapeutics | 78 |
| Fennec Pharmaceuticals | 35 |
| Elicio Therapeutics | 33 |
CDXS News
- 4 weeks ago - Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - PRNewsWire
- 6 weeks ago - Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewsWire
- 2 months ago - Codexis Achieves ISO 9001:2015 Certification - GlobeNewsWire
- 3 months ago - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - PRNewsWire
- 5 months ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire
- 5 months ago - Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing - PRNewsWire
- 6 months ago - Codexis to Report Third Quarter 2025 Financial Results on November 6 - GlobeNewsWire